Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, Washington.
Department of Medicine, University of Washington, Seattle, Washington.
Semin Respir Crit Care Med. 2023 Jun;44(3):405-414. doi: 10.1055/s-0043-1766116. Epub 2023 Apr 4.
While the cannabis industry is one of the fastest growing job markets in the United States and globally, relatively little is known about the occupational hazards that cannabis production workers face. Based on the closely related hemp industry and preliminary studies from recreational cannabis grow facilities, there is concern for significant respiratory exposures to bioaerosols containing microbial and plant allergens, chemicals such as pesticides, volatile organic compounds, and other irritant gases. Components of the cannabis plant have also recently been identified as allergenic and capable of inducing an immunoglobulin E-mediated response. Accumulating evidence indicates a spectrum of work-related respiratory diseases, particularly asthma and other allergic diseases. Disentangling causal relationships is difficult given the heterogeneity of mixed exposures, diagnostic challenges, and confounding by personal cannabis use. Despite and because of these uncertainties, better regulatory guidance and exposure controls need to be defined in order to reduce the risk of work-related disease.
虽然大麻产业是美国和全球发展最快的就业市场之一,但对于大麻生产工人所面临的职业危害,人们知之甚少。基于密切相关的大麻产业和来自娱乐性大麻种植设施的初步研究,人们担心会对含有微生物和植物过敏原、农药、挥发性有机化合物和其他刺激性气体的生物气溶胶产生重大呼吸暴露。大麻植物的成分最近也被确定为过敏原,并能够引发免疫球蛋白 E 介导的反应。越来越多的证据表明存在一系列与工作相关的呼吸道疾病,特别是哮喘和其他过敏性疾病。鉴于混合暴露的异质性、诊断挑战以及个人使用大麻的混杂因素,很难理清因果关系。尽管存在这些不确定性,但仍需要制定更好的监管指导和暴露控制措施,以降低与工作相关的疾病风险。